Quarterly Protein Product and Data Update: Edition #2
Thursday, August 03, 2017 - 14:27
New Products
New! Human Anti-Zika Virus IgG ELISA Kit
R&D Systems now offers an Anti-Zika Virus IgG ELISA to measure anti-Zika virus (ZIKV) IgG antibodies in human serum. In-house testing shows that R&D Systems® assay is more specific and sensitive than three other commercially available anti-ZIKV IgG ELISA kits. Learn More!
R&D Systems now offers an Anti-Zika Virus IgG ELISA to measure anti-Zika virus (ZIKV) IgG antibodies in human serum. In-house testing shows that R&D Systems® assay is more specific and sensitive than three other commercially available anti-ZIKV IgG ELISA kits. Learn More!
GMP, Animal Component-free Recombinant Human TGF-β and Fibronectin are now available!
Fibronectin and TGF-β can be important raw materials for culturing cells for cell therapy or regenerative medicine. GMP grade animal-free recombinant versions of these proteins have not been available… until now!
Fibronectin and TGF-β can be important raw materials for culturing cells for cell therapy or regenerative medicine. GMP grade animal-free recombinant versions of these proteins have not been available… until now!
New Bioactive Slit and ROBO Proteins Exclusively from R&D Systems!
Perhaps best known for roles in axon guidance and neurite outgrowth, Slits and their ROBO receptors are increasingly recognized for morphogenic and tumorigenic functions. Learn More About Recombinant Slit and Robo Proteins!
Perhaps best known for roles in axon guidance and neurite outgrowth, Slits and their ROBO receptors are increasingly recognized for morphogenic and tumorigenic functions. Learn More About Recombinant Slit and Robo Proteins!
Novel Adipokines and Myokines: Irisin, Meteorin-like, CTRP/C1qTNF Family, and more
These new proteins are potential drug targets and regulators of diabetes, insulin resistance, obesity, and cardiovascular disease. Learn More About Adipokines and Myokines!
These new proteins are potential drug targets and regulators of diabetes, insulin resistance, obesity, and cardiovascular disease. Learn More About Adipokines and Myokines!
Butyrophilins: Novel Immunomodulatory Proteins with Structure and Functions Similar to the B7 family
See the new bioactive proteins available and data that highlight the immunosuppressive activity of these novel immuno-oncology drug targets. Learn More About Butyrophilins!
See the new bioactive proteins available and data that highlight the immunosuppressive activity of these novel immuno-oncology drug targets. Learn More About Butyrophilins!
Webinars
Sign up for our upcoming Webinar! A New Immunoassay for Detecting Zika Virus IgG with Very Low Dengue Virus Cross-reactivity
Please join us for a webinar to discuss the development of a new serological Zika Virus IgG Test. Our panel of experts will be on hand to explain the need for this kit and to answer questions about how the assay was developed and tested. Sign up Now to View the Zika Webinar!
Please join us for a webinar to discuss the development of a new serological Zika Virus IgG Test. Our panel of experts will be on hand to explain the need for this kit and to answer questions about how the assay was developed and tested. Sign up Now to View the Zika Webinar!
Webinar: Next generation Immuno-Oncology Targets
R&D Systems Development Scientist, Anthony Person Ph.D., highlights VSIG3 as an immunosuppressive protein and ligand for Vista, B7-related Butyrophilins, and novel LILRA/B interactions. Watch the Immuno-Oncology Webinar Now!
R&D Systems Development Scientist, Anthony Person Ph.D., highlights VSIG3 as an immunosuppressive protein and ligand for Vista, B7-related Butyrophilins, and novel LILRA/B interactions. Watch the Immuno-Oncology Webinar Now!
Resources
Expand NK and CIK Cells from PBMCs: New Cytokine Cocktails and Optimized Protocols Make It Easy!
Our kits contain cytokine cocktails and optimized protocols to reproducibly expand CD3-CD56+ Natural Killer (NK) cells or CD3+CD56+ Cytokine-induced Killer (CIK) Cells for PBMCs. Learn More about CellXVivo™ Expansion Kits!
Our kits contain cytokine cocktails and optimized protocols to reproducibly expand CD3-CD56+ Natural Killer (NK) cells or CD3+CD56+ Cytokine-induced Killer (CIK) Cells for PBMCs. Learn More about CellXVivo™ Expansion Kits!
New paper from R&D Systems: Non-reducing End Labeling of Heparan Sulfate and a High Throughput ELISA for Heparanase
This paper highlights the first enzymatic labeling method for glycosaminoglycans and the first high-throughput, enzymatic assay for endoglycosidases. Detect and image glycosaminoglycans, including hyaluronan and chondroitin sulfate, as well as screen for inhibitors to degradation endoglycosidases. Read Our Paper Now!
This paper highlights the first enzymatic labeling method for glycosaminoglycans and the first high-throughput, enzymatic assay for endoglycosidases. Detect and image glycosaminoglycans, including hyaluronan and chondroitin sulfate, as well as screen for inhibitors to degradation endoglycosidases. Read Our Paper Now!
Blog Categories: